Biotech companies in the United States by P/S ratio

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

CG Oncology leads the 15 biotech companies in the United States ranked by P/S ratio, at 1806, ahead of Kymera Therapeutics (262) and ImmunityBio (60.6). Figures as of 19 Nov 2026, 20:11 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
15
First
CG Oncology1806
Median
14.7
Combined market value
$734.2B
Countries
1
Not ranked
5no P/S ratio on file

Market values as of .

United States
All sectors
Biotech
USD
Clear filters
Biotech companies in the United States by P/S ratio
#CompanyP/S ↓Market capPriceToday1 yearPrice, 30 daysCountry
1CG OncologyCGON · Health Care1806$7.3B$81.67 2.09% up 97% up United States
2Kymera TherapeuticsKYMR · Health Care262$10.3B$120.20 0.77% down 87% up United States
3ImmunityBioIBRX · Health Care60.6$6.9B$6.46 3.66% down 232% up United States
4ModernaMRNA · Health Care41.3$80.4B$198.62 0.93% up 780% up United States
5Krystal BiotechKRYS · Health Care23.9$9.3B$314.40 0.30% down 54% up United States
6Twist BioscienceTWST · Health Care20.1$7.6B$110.83 4.74% down 346% up United States
7Adaptive BiotechnologiesADPT · Health Care16.5$4.6B$28.30 0.56% down 74% up United States
8RepligenRGEN · Health Care14.7$10.8B$169.42 1.88% down 12% up United States
9Bio-TechneTECH · Health Care9.4$11.4B$72.72 0.05% down 24% up United States
10Halozyme TherapeuticsHALO · Health Care7.6$10.5B$92.49 3.46% down 39% up United States
11Gilead SciencesGILD · Health Care7.0$206.4B$166.42 1.51% down 35% up United States
12ExelixisEXEL · Health Care6.9$16B$65.77 3.69% down 63% up United States
13AmgenAMGN · Health Care6.5$237.3B$438.65 1.18% down 32% up United States
14Neurocrine BiosciencesNBIX · Health Care5.6$16B$157.99 2.99% down 17% up United States
15BiogenBIIB · Health Care3.7$36.5B$246.62 1.91% down 49% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. P/S divides today's market value by the latest fiscal year's revenue from the annual report. 5 companies have no P/S ratio on file and are not ranked here.

Questions and answers

Which biotech companies in the United States rank first by P/S ratio?

CG Oncology (1806), Kymera Therapeutics (262) and ImmunityBio (60.6) are the top three of the 15 biotech companies in the United States ranked by P/S ratio as of 19 Nov 2026, 20:11 UTC.

How many biotech companies in the United States are in this ranking?

15 are ranked by P/S ratio. 5 more have no P/S ratio on file and are left out rather than ranked at zero.

What are these biotech companies in the United States worth together?

The 15 biotech companies in the United States ranked by P/S ratio have a combined market value of $734.2B as of 19 Nov 2026, 20:11 UTC.

What does ranking by P/S ratio measure?

Market value divided by the latest fiscal year's revenue: what the market pays for each dollar of sales.

Cite this page

Funkfolio, “Biotech companies in the United States by P/S ratio”, data as of 19 November 2026. https://funkfolio.com/companies/category/biotech?country=united-states&by=ps-ratio

Underlying data: Yahoo Finance; SEC EDGAR.